Page 10 of 32

PA24.{2,4} | Alcoholic Liver Disease, Cirrhosis & Hepatic Failure — SDL Guide

Learning Objectives

Describe the three-stage spectrum of alcoholic liver disease: steatosis, alcoholic hepatitis, and cirrhosis — their reversibility, morphology, and pathogenesis via acetaldehyde and oxidative stress.
Identify the histological hallmarks of alcoholic hepatitis: hepatocyte ballooning, Mallory-Denk bodies, and neutrophilic infiltrate.
Define cirrhosis and distinguish micronodular from macronodular patterns; enumerate the major aetiologies.
Explain the pathophysiology of acute (fulminant) and chronic hepatic failure, and correlate each clinical complication — jaundice, encephalopathy, coagulopathy, portal hypertension consequences, hepatorenal and hepatopulmonary syndromes — with its underlying mechanism.
Briefly describe the Child-Pugh scoring concept and its clinical utility.

INSTRUCTIONS

The liver processes everything you eat, drink, and absorb — when it fails, every organ system feels the consequences. Alcohol is the most common toxic cause of chronic liver disease worldwide, and its three-stage spectrum illustrates how a reversible metabolic insult can burn through to permanent architectural destruction. Understanding this progression unlocks the mechanisms behind cirrhosis, portal hypertension, and hepatic failure — complications you will encounter in wards, surgery, and medicine clinics throughout your career. This module builds on Year-1 biochemistry (lipid metabolism, NADH/NAD+ ratio, oxidative stress) and hepatocyte ultrastructure from Anatomy.

References

Robbins & Cotran Pathologic Basis of Disease, 10th ed., Ch 18 — Liver and Biliary Tract (textbook)
Harsh Mohan's Textbook of Pathology, 8th ed., Ch 19 — Pathology of the Liver (textbook)

Version 2.0 | NMC CBUC 2024

CLINICAL SCENARIO

A 44-year-old man presents with a massively distended abdomen, yellow sclera, and confusion — he cannot say where he is. His wife says he has been drinking heavily for 15 years. Ultrasound shows a shrunken nodular liver with ascites. Coagulation studies return uncorrectable. His ammonia is 140 µmol/L.

What has gone wrong? And why does a damaged liver make a patient bleed, swell, and lose their mind — all at once?

WHY THIS MATTERS

Alcoholic liver disease is the leading cause of cirrhosis in most urban Indian hospitals. Hepatic failure — the end-stage consequence — carries a 30-day mortality of 50–90% in the fulminant form. Every complication you will manage in medicine and surgery rounds traces back to the pathological mechanisms covered here: failed synthetic function, altered haemodynamics, and toxic metabolite accumulation. This SDL also lays the foundation for SDL 4 (Portal Hypertension & Hepatic Tumours) and the clinical pharmacology of alcohol you will meet in Phase 3.

RECALL

Before continuing, confirm you can answer:
• What is the role of NADH/NAD+ ratio in hepatic lipid metabolism? (Year-1 Biochemistry)
• Which hepatic zone (zone 1/2/3) is most oxygen-poor and therefore most vulnerable to toxic injury? (Year-1 Anatomy)
• What is the difference between conjugated and unconjugated bilirubin, and which fraction rises first in hepatocellular disease? (Year-1 Physiology)

If uncertain, a quick review of those concepts now will make the mechanisms below significantly clearer.

Overview: The Three-Stage Spectrum of Alcoholic Liver Disease

Diagram showing alcoholic liver disease progressing from steatosis to hepatitis to cirrhosis, linked to ethanol metabolism through acetaldehyde and increased NADH production. — **Panel A:** Hepatic steatosis, Alcoholic hepatitis, Alcoholic cirrhosis, reversible stages, irreversible cirrhosis, fat droplets, inflammatory cells, fibrous septa, regenerative nodules, 10-20% progression note. **Panel B:** Ethanol, alcohol dehydrogenase (ADH), acetaldehyde, aldehyde dehydrogenase (ALDH), acetate, NAD+, NADH, increased NADH:NAD+ ratio, acetaldehyde direct toxicity. **Panel C:** Increased triglyceride synthesis, decreased β-oxidation of fatty acids, decreased gluconeogenesis, CYP2E1 oxidative stress, stellate-cell activation, collagen deposition, fibrosis.

Alcohol (ethanol) causes liver injury in a predictable, dose-dependent three-stage progression:

Hepatic steatosis (fatty liver) — reversible
Alcoholic hepatitis — reversible if alcohol is stopped early, may progress
Alcoholic cirrhosis — irreversible

The critical insight is that only 10–20% of heavy drinkers progress to cirrhosis; individual susceptibility (genetic, nutritional, co-infections) determines outcome. Each stage represents a quantitative increase in hepatocyte damage and a qualitative change in fibroblast/stellate-cell activation.

The key metabolic driver is ethanol oxidation via alcohol dehydrogenase (ADH) and ALDH, producing acetaldehyde (direct toxin) and NADH (↑NADH/NAD+ ratio). The shifted redox state inhibits β-oxidation of fatty acids, promotes triglyceride synthesis, and blocks gluconeogenesis — together these produce fat accumulation (steatosis).

Diagram showing ethanol metabolism by ADH and ALDH in hepatocytes, increased NADH:NAD+ ratio, triglyceride accumulation, reduced beta-oxidation, and CYP2E1-related oxidative stress. — **Panel A:** Ethanol, alcohol dehydrogenase (ADH), acetaldehyde, aldehyde dehydrogenase (ALDH), acetate, NAD+, NADH, elevated NADH:NAD+ ratio, cytosol, mitochondrion.. **Panel B:** Decreased fatty acid beta-oxidation, increased triglyceride synthesis, fat accumulation in hepatocyte, macrovesicular steatosis, peripheral nucleus, reversible early alcoholic fatty liver.. **Panel C:** CYP2E1, reactive oxygen species, oxidative stress, lipid peroxidation, hepatocyte injury, acetaldehyde-protein adducts, impaired VLDL assembly/export, NAFLD/NASH comparison note..

Note: NAFLD/NASH (non-alcoholic fatty liver disease / non-alcoholic steatohepatitis) mirrors alcoholic steatosis and hepatitis histologically but occurs in the context of metabolic syndrome (obesity, insulin resistance, type 2 diabetes) rather than alcohol. This underscores that steatosis and hepatocyte injury are final common pathways, not alcohol-specific responses.

Stage 1: Hepatic Steatosis (Alcoholic Fatty Liver)

Four-panel diagram explaining alcoholic hepatic steatosis through gross liver appearance, metabolic mechanisms, macrovesicular histology, and reversibility with abstinence. — **Panel A:** Enlarged yellow greasy liver, normal liver size comparison, hepatomegaly, soft fatty appearance. **Panel B:** Ethanol metabolism, increased NADH/NAD+ ratio, inhibited fatty acid beta-oxidation, acetaldehyde, impaired VLDL assembly, increased SREBP-1c, de novo lipogenesis, triglyceride accumulation. **Panel C:** Macrovesicular fat vacuole, peripheral displaced nucleus, hepatocyte, centrilobular vein, zone 3 predominance, H&E stain, 200x view. **Panel D:** Usually asymptomatic, hepatomegaly on examination, mild or normal LFTs, abstinence for 4-6 weeks, complete reversibility.

Hepatic steatosis is the earliest, mildest, and fully reversible stage of alcoholic liver disease.

Pathogenesis — three converging mechanisms:
• ↑NADH/NAD+ ratio → inhibits fatty acid β-oxidation → fatty acids accumulate in hepatocytes
• Acetaldehyde directly disrupts lipid export (impairs VLDL assembly)
• ↑De novo lipogenesis via upregulated SREBP-1c

Gross morphology: Liver is enlarged (hepatomegaly), yellow, greasy, soft. May reach 4–6 kg.

Microscopy:
• Macrovesicular steatosis — large fat vacuoles pushing the nucleus to the periphery ("signet-ring" appearance)
• Predominantly zone 3 (centrilobular) distribution — highest alcohol/oxygen exposure
• No significant inflammation or fibrosis at this stage

Clinical: Usually asymptomatic. Hepatomegaly on examination. LFTs mildly elevated (or normal). Completely reversible with abstinence within 4–6 weeks — this is the key clinical message.

A medical histology figure shows macrovesicular steatosis with large clear fat vacuoles displacing hepatocyte nuclei, concentrated around the centrilobular vein in zone 3. — **Panel A:** H&E 200x liver histology showing macrovesicular fat vacuoles, peripheral displaced nuclei, ballooned hepatocytes, and centrilobular vein with zone 3 predominance. **Panel B:** Simplified liver acinus showing portal tract, central vein, zones 1, 2, and highlighted zone 3 distribution. **Panel C:** Cellular close-up comparing normal hepatocyte with steatotic hepatocyte containing a large lipid droplet and peripherally displaced nucleus.

Stage 2: Alcoholic Hepatitis

Diagram of alcoholic hepatitis showing zone 3 hepatocyte injury, Mallory-Denk bodies, neutrophilic satellitosis, perivenular fibrosis, inflammatory pathogenesis, and clinical laboratory clues. — **Panel A:** Main liver lobule histology showing central vein, zone 3 perivenular region, steatosis, hepatocyte ballooning degeneration, Mallory-Denk bodies, neutrophilic satellitosis, and early perivenular fibrosis.. **Panel B:** Acetaldehyde-mediated hepatocyte injury pathway showing ethanol metabolism, acetaldehyde-protein adducts, cytokeratin 8/18 disruption, ballooning, and necrosis.. **Panel C:** Gut-liver inflammatory axis showing alcohol-induced gut permeability, endotoxin translocation, Kupffer cell activation, TNF-alpha, IL-1, IL-6 release, and neutrophil recruitment.. **Panel D:** Magnified four histological hallmarks: ballooned hepatocyte, Mallory-Denk body, neutrophilic infiltrate/satellitosis, and zone 3 perivenular fibrosis.. **Panel E:** Clinical and laboratory clues showing fever, right upper quadrant pain, jaundice, hepatomegaly, AST:ALT ratio greater than 2:1, and markedly elevated GGT..

Alcoholic hepatitis develops with continued alcohol use and represents hepatocyte necrosis superimposed on steatosis.

Pathogenesis: Acetaldehyde forms protein adducts → disrupts cytoskeleton → hepatocyte ballooning and necrosis. Endotoxin translocation from gut (alcohol-induced dysbiosis and increased gut permeability) activates Kupffer cells → release of TNF-α, IL-1, IL-6 → neutrophilic recruitment.

Histological hallmarks — all four must be known:

Hepatocyte ballooning degeneration — swollen, pale hepatocytes with wispy, cleared cytoplasm (reflects cytoskeletal injury)
Mallory-Denk bodies (MDB) — irregular, eosinophilic cytoplasmic inclusions composed of misfolded cytokeratin 8/18 intermediate filaments. Pathognomonic of alcoholic hepatitis, though also seen in NASH and Wilson disease. They represent the morphological signature of severe cytoskeletal damage.
Neutrophilic infiltrate — neutrophils (not lymphocytes) surround and invade damaged hepatocytes (satellitosis) — this neutrophil-dominant pattern distinguishes alcoholic hepatitis from viral hepatitis
Perivenular (zone 3) fibrosis — early collagen deposition around the central vein (precursor to bridging fibrosis)

Clinical: May present acutely with fever, right upper quadrant pain, jaundice, hepatomegaly. AST:ALT ratio >2:1 is a classic clue (alcohol also inhibits ALT synthesis, a pyridoxal phosphate-dependent enzyme). Serum GGT markedly elevated (alcohol-specific inducer of CYP2E1 pathway).

Stylized H&E histology diagram of alcoholic hepatitis showing hepatocyte ballooning, Mallory-Denk bodies, and neutrophil satellitosis with labeled magnified insets. — **Panel A:** Alcoholic hepatitis at 400x H&E showing disrupted hepatic cords, ballooned hepatocytes, eosinophilic Mallory-Denk inclusions, neutrophilic inflammation, and sinusoids.. **Panel B:** Hepatocyte ballooning shown as enlarged pale swollen hepatocytes with rarefied cytoplasm and displaced nuclei.. **Panel C:** Mallory-Denk bodies shown as pink rope-like eosinophilic cytoplasmic inclusions within injured hepatocytes.. **Panel D:** Neutrophil satellitosis shown as clusters of multilobed neutrophils surrounding an injured ballooned hepatocyte..

SELF-CHECK

A liver biopsy from a chronic alcohol user shows ballooned hepatocytes with irregular, rope-like eosinophilic cytoplasmic inclusions surrounded by neutrophils. What are these inclusions composed of?

A. Misfolded cytokeratin 8/18 intermediate filaments

B. Aggregated alpha-1-antitrypsin polymers

C. Copper-metallothionein complexes

D. Hepatitis B surface antigen

Reveal Answer

Answer: A. Misfolded cytokeratin 8/18 intermediate filaments

Mallory-Denk bodies are composed of misfolded cytokeratin 8 and 18 intermediate filaments. They are the histological hallmark of alcoholic hepatitis, though they also appear in NASH and Wilson disease. Alpha-1-antitrypsin globules (PAS-positive, diastase-resistant) are seen in alpha-1-antitrypsin deficiency. Copper complexes characterise Wilson disease. HBsAg produces the ground-glass hepatocyte appearance.